Search For "bharat biotech international limited"
Bharat Biotech to advance development of GSK's Shigella vaccine candidate
Updated : 12 months ago IST
Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and manufacturing on Thursday announced that it has partnered with GSK plc (LSE/NYSE: GSK) for the ongoing development and potential use of the Shigella vaccine candidate, altSonflex1-2-3.
Read More
iNCOVACC is a testimony to innovative zeal of our scientists: Mansukh Mand
Updated : 3 years, 4 months ago IST
Mandaviya unveiled the Inncovacc- the first India-made nasal Covid-19 vaccine today in the presence of Union Minister of State (IC) for Science and Technology, Jitendra Singh.
Read More
India-made iNCOVACC, world's first intra-nasal vaccine to receive approval
Updated : 3 years, 6 months ago IST
iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced
Read More
Nigeria introduces Bharat Biotech's Rotavac vaccine to immunise children
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], August 24 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer, on Wednesday announced that its rotavirus oral vaccine ROTAVAC has been introduced to immunise its children from the life-threatening diarrhoeal
Read More
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press
Read More
Indian Immunologicals hands over first lot of Covaxin drug substance to Bh
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], August 13 (ANI): In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get vaccinated at the earliest, the Central Government requested that Indian Immunologicals Limited (IIL) and Bha
Read More
COVAXIN shows 81 pc efficiency in phase three trials, says ICMR
Updated : 5 years, 3 months ago IST
New Delhi [India], March 3 (ANI): Phase three results of the COVAXIN, a vaccine against COVID-19 which has been developed by Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited (BBIL), has shown an interim vaccine efficacy of 81 per cent in p
Read More
'A powerful example for all Indians': Bharat Biotech after PM Modi receive
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], March 1 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer that developed the country's indigenous COVID-19 vaccine, Covaxin, on Monday welcomed Prime Minister Narendra Modi's gesture of taking the first do
Read More
Bharat Biotech confirms deal with Brazil to supply 20 million doses of Cov
Updated : 5 years, 3 months ago IST
New Delhi [India], February 26 (ANI): Bharat Biotech International Limited on Friday confirmed that the company has signed an agreement with Brazil for the supply of 20 million doses of Covaxin vaccine.
Read More
Bharat Biotech dispatches COVID-19 vaccine Covaxin to 11 cities, donates 1
Updated : 5 years, 4 months ago IST
Hyderabad (Telangana) [India], January 13 (ANI): The Bharat Biotech International Limited (BBIL) has announced the successful air-shipment of its COVID-19 vaccine 'Covaxin' to 11 cities in the country in the early hours of Wednesday.
Read More
Bharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccin
Updated : 5 years, 5 months ago IST
New Delhi [India], January 8 (ANI): The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday.
Read More
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clin
Updated : 5 years, 5 months ago IST
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
Read More